Antiva Biosciences, Inc. of Redwood City, CA, a company, filed a Form D amendment with the SEC on 2013-09-05. The offering totals $1.1M, of which $1.1M was reported sold. Industry: Biotechnology.
Showing 25 of 41 people.
| Name | Role | Location |
|---|---|---|
| Karl Y Hostetler | Director | Del Mar, CA |
| William Y Respess | Director | Del Mar, CA |
| Karl Y Hostetler | Executive Officer | Del Mar, CA |
| Michael J Sullivan | Executive Officer | San Francisco, CA |
| David P Kabakoff | Director | Beltsville, MD |
| Steven James | Director | REDWOOD CITY, CA |
| Clifford Samuel | Director | Redwood City, CA |
| Beni Rovinski | Director | Redwood City, CA |
| Florencia Segal | Director | Redwood City, CA |
| Gail Maderis | Director | Redwood City, CA |
| Gail Maderis | Executive Officer | Redwood City, CA |
| Kristine Ball | Director | Redwood City, CA |
| Kristine Ball | Executive Officer | Redwood City, CA |
| Elaine Chien | Executive Officer | Redwood City, CA |
| Brian Goodman | Director | Redwood City, CA |
| Wende Hutton | Director | Menlo Park, CA |
| Sarah Walter | Executive Officer | Redwood City, CA |
| Raju Gadiraju | Executive Officer | Redwood City, CA |
| Michael Cannon | Director | Emeryville, CA |
| Oranee Daniels | Executive Officer | BRISBANE, CA |
| Jenny Yip | Director | BRISBANE, CA |
| Benjamin Rovinski | Director | Mendham, NJ |
| Vinzenz Ploerer | Director | Brisbane, CA |
| David Kabakoff | Director | Brisbane, CA |
| Michael D Cannon | Director | Emeryville, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-10-11 | D/A | $53.0M | $38.5M |
| 2023-05-05 | D | $53.0M | $26.6M |
| 2021-11-03 | D | $31.0M | $15.6M |
| 2018-07-19 | D | $15.0M | $15.0M |
| 2017-08-28 | D/A | $25.9M | $14.7M |
| 2017-04-05 | D | $22.3M | $11.1M |
| 2015-06-11 | D | $16.0M | $8.9M |
| 2014-12-23 | D | $2.5M | $1.7M |
| 2014-07-10 | D | $1.3M | $1.1M |
| 2013-03-06 | D | $1.0M | $501K |